Newsroom / Viral Pathogens

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some of the news content posted here.

by Neoteryx, on March 17,2021

AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …

Read Story
Topics:

by Neoteryx, on September 23,2020

LOS ANGELES and Cambridge, UK — September 2020 — The first commercially available SARS-CoV-2 antibody test in the UK compatible with Neoteryx’s Mitra® Microsampling device for at-home blood collection has …

Read Story
Topics:

by Neoteryx, on April 27,2020

ROCHESTER, NY — Researchers around the globe are racing to respond to the COVID-19 pandemic. At the University of Rochester in the Clinical and Translational Science Institute (CTSI), researcher and …

Read Story
Topics:

by Neoteryx, on April 10,2020

BETHESDA, MD — A new study has begun recruiting at the National Institutes of Health in Bethesda, Maryland to determine how many adults in the United States without a confirmed …

Read Story
Topics:

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news